We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Handheld Hemodynamic Ultrasound System Aids Real-Time Decision Making for Critically Ill ICU Patients

By MedImaging International staff writers
Posted on 30 Jun 2022
Print article
Image: Zura handheld hemodynamic ultrasound system (Photo courtesy of Clarius)
Image: Zura handheld hemodynamic ultrasound system (Photo courtesy of Clarius)

The world's first handheld transesophageal echocardiography (TEE) system designed to manage and guide care for the most critically ill patients in the ICU enables more clinicians to accurately determine appropriate interventions in real-time.

Clarius Mobile Health (Vancouver, BC, Canada) and ImaCor Inc. (Jericho, NY, USA) have entered into a partnership that enables the availability of the world's first handheld TEE system designed to manage and guide care for the most critically ill patients in the ICU. The Zura Handheld Hemodynamic Ultrasound system powered by Clarius provides an instant, clear window to directly visualize preload and contractility over time, having received clearance by the U.S. Food and Drug Administration to help clinicians make the right decisions, at the right time.

The Zura Handheld Hemodynamic Ultrasound system is the companion device to the ClariTEE transesophageal echo probe. Now powered by Clarius, they comprise the first and only advanced handheld hemodynamic management platform for real-time decision making to care for the most at-risk patients. Pocket-sized, the 22-ounce handheld is a key advantage in the ICU where space is limited. The Zura Handheld operates with the Clarius Ultrasound App, which connects wirelessly to Apple and Android smart devices.

"A high-risk patient's hemodynamic status changes dramatically in a matter of minutes, often while clinicians are waiting for test results they submitted 15 minutes ago," said ImaCor's Founder, Scott Roth, MD. "The Zura Handheld provides instant and accurate information to guide patient management and it's proven to save lives. More than 20,000 patients have already benefitted from our cart-based Zura system. We're excited to make this life-saving device now highly accessible to more high acuity care teams with the introduction of our handheld system, which is easier to bring to the bedside, can be used to monitor multiple patients in real-time, and takes up no floor space. We chose to partner with Clarius for our handheld solution, because it delivers the highest image quality for the best patient care."

"Our collaboration with ImaCor is a powerful example of how Clarius is broadening access to medical imaging and helping clinicians to provide better specialized patient care," said Clarius Founder Laurent Pelissier. "We have intentionally designed our app-based ultrasound system to push the boundaries of medical imaging. It's an honor to work with Dr. Roth and his team to make his vision for better acute care a reality, improving patient care and saving lives."

Related Links:
Clarius Mobile Health 
ImaCor Inc. 

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Wireless Handheld Ultrasound System
TE Air
Oncology Information System
RayCare
New
Brachytherapy Planning System
Oncentra Brachy

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.